<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15566">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02904239</url>
  </required_header>
  <id_info>
    <org_study_id>16-4-116</org_study_id>
    <nct_id>NCT02904239</nct_id>
  </id_info>
  <brief_title>Evaluation of Cardiac Pathologies on Thoracic CT</brief_title>
  <acronym>CaPaCT-II</acronym>
  <official_title>Evaluation of Cardiac Pathologies in Thoracic CT Using Individualised Contrast Media Protocols and Ultra High-Pitch Mode [CaPaCT-2]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      New technical developments make ultra-fast non-electrocardiogram (ECG) triggered scan
      acquisition with a high temporal resolution possible, which can be used for the evaluation
      of cardiac pathologies on a standard thoracic Computed Tomography (CT) scans.

      Current studies have shown that it is possible to assess the heart and it's coronary
      arteries on standard ultra-high pitch thoracic CT, which could result in incidental or new
      cardiac findings. However, to be able to perform a complete cardiopulmonary assessment on a
      thoracic CT scan, the injection protocol and bolus tracking settings could be optimised for
      both aortic and pulmonary vasculature (e.g. sufficient attenuation in pulmonary arteries,
      pulmonary trunk and ascending aorta).

      Therefore, the aim of the study is to evaluate the presence and extent of coronary artery
      disease, valvular morphology and calcification, pericardial abnormalities, and cardiac size
      on a standard ultra-high pitch thoracic CT-scan with individualised injection protocols.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality</measure>
    <time_frame>one year</time_frame>
    <description>Evaluation of subjective and objective image quality based on individualized thoracic CT protocols</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Performance of optimised injection protocols</measure>
    <time_frame>one year</time_frame>
    <description>Evaluation of the performance of optimised injection protocols with regard to the detection of coronary artery disease on standard thoracic CT-scans</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection rate and presence of coronary artery disease (CAD)</measure>
    <time_frame>one year</time_frame>
    <description>Detection rate of presence of CAD and comparison to detection rate on standard CT scans without contrast optimisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation dose reduction</measure>
    <time_frame>one year</time_frame>
    <description>Comparing the individualised tube voltage settings with regard to contrast media (CM) volume reduction</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Coronary Artery Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients referred for thoracic CT-scanning.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Standard non-ECG triggered thoracic CT scanning.

        Exclusion Criteria:

          -  Severe allergy against Iopromide or any of the ingredients,

          -  Previous severe CM reaction (according to current European Society of Urogenital
             Radiology (ESUR) guidelines),

          -  Renal insufficiency, pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marco Das, MD, PhD</last_name>
    <phone>+31433874910</phone>
    <email>m.das@mumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nienke Eijsvoogel, MD</last_name>
    <phone>+31433874910</phone>
    <email>nienke.eijsvoogel@mumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6202AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nienke Eijsvoogel, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Babs Hendriks, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Marco Das, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 8, 2017</lastchanged_date>
  <firstreceived_date>September 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Maastricht University Medical Center</investigator_affiliation>
    <investigator_full_name>Joachim Wildberger</investigator_full_name>
    <investigator_title>MD, PhD, Prof</investigator_title>
  </responsible_party>
  <keyword>Contrast Media</keyword>
  <keyword>Multidetector Computed Tomography</keyword>
  <keyword>Individualized Medicine</keyword>
  <keyword>Radiation Dosage</keyword>
  <keyword>Incidental cardiac findings</keyword>
  <keyword>Thoracic high-pitch Computed Tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
